Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare skin disorder characterized by erythrodermic, peeling skin from birth with no obvious nail or hair-shaft abnormalities and other associated anomalies including diarrhea, failure to thrive and severe hypoalbuminaemia resistant to correction by enteral or intravenous supplementation. An autosomal recessive mode of inheritance is highly probable. The prognosis is poor and infants die in the first months of life. There have been no further descriptions in the literature since 1992.
Features include: Congenital exfoliative erythroderma, Failure to thrive, and Hypoalbuminemia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Pregnancy and birth | 1 | Congenital exfoliative erythroderma |
Growth and development |
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 2:15 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1
Failure to thrive |
AI-curated news mentioning congenital lethal erythroderma
Updated Jul 21, 2026
A recent study published in PubMed highlights a case of multicentric reticulohistiocytosis that progressed to erythroderma after long-term disease progression. This research adds to the understanding of disease progression in rare conditions.
A recent study highlights graft-versus-host disease-like erythroderma as a rare paraneoplastic disorder associated with thymoma. This discovery adds to the understanding of the complex interactions between tumors and immune responses.